Saturday, May 18, 2013 5:08pm EDT
PACB - Pacific Biosciences of California, Inc. - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
MNov 30 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 154,100 | Purchase at $1.75 | $270,248 | |
MNov 27 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 242,200 | Purchase at $1.68 | $406,627 | |
MNov 21 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 186,400 | Purchase at $1.44 | $269,238 | |
MNov 19 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 155,000 | Purchase at $1.27 | $196,116 | |
MNov 14 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 262,300 | Purchase at $1.16 | $303,610 | |
MAug 6 2012 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Chairman, CEO, President | 400,000 | Purchase at $1.75 | $699,785 | |
MFeb 3 2012 | PACB | Pacific Biosciences of California Inc | Martin Hugh C | Director | 69,174 | Option exercise at $1.01 | $69,542 | |
Feb 7 2012 | PACB | Pacific Biosciences of California Inc | Martin Hugh C | Director | 108,009 | Other Sale at $0.00 | $0 | |
Aug 10 2011 | PACB | Pacific Biosciences of California Inc | Siegel Susan E | Director | 65,000 | Option exercise at $0.70 | $45,500 | |
MAug 9 2011 | PACB | Pacific Biosciences of California Inc | Hunkapiller Michael | Director | 100,000 | Purchase at $5.77 | $577,208 | |
Jul 11 2011 | PACB | Pacific Biosciences of California Inc | Turner Stephen W | VP, CTO | 67,900 | Other Purchase at $0.00 | $0 | |
MJun 1 2011 | PACB | Pacific Biosciences of California Inc | Turner Stephen W | VP, CTO | 2,186,126 | Gift at $0.00 | $0 | |
MJul 1 2011 | PACB | Pacific Biosciences of California Inc | Turner Stephen W | VP, CTO | 67,900 | Sale at $12.05 | $818,032 | |
May 27 2011 | PACB | Pacific Biosciences of California Inc | Martin Hugh C | Chairman, CEO, President | 38,835 | Option exercise at $1.96 | $76,117 |
D Derivative transaction exists
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance